CG Oncology (CGON) Receivables - Net (2023 - 2026)

CG Oncology's (CGON) quarterly Receivables - Net came in at $1.3 million in Q1 2026, up 269.57% YoY from $345000.0 in Q1 2025, and up 85.32% on a QoQ basis from $688000.0 in Q4 2025.

CG Oncology (CGON) Receivables - Net (2023 - 2026) Analysis & Trends

CG Oncology (CGON) has 4 years of Receivables - Net data on file, last reported at $1.3 million in Q1 2026.

  • Quarterly Receivables - Net rose 269.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 269.57% YoY) and the FY2025 annual result came in at $688000.0, changed N/A from the prior year.
  • Receivables - Net rose to $1.3 million in Q1 2026, from $688000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.3 million in Q1 2026 to a low of $92000.0 in Q4 2023.
  • A 4-year average of $438777.8 and a median of $345000.0 in 2025 frame the typical range for Receivables - Net.
  • The widest YoY moves for Receivables - Net: up 275.91% in 2025, down 125.49% in 2025.
  • Tracing CGON's Receivables - Net over 4 years: stood at $92000.0 in 2023, then jumped by 48.91% to $137000.0 in 2024, then surged by 402.19% to $688000.0 in 2025, then jumped by 85.32% to $1.3 million in 2026.
  • The last three Receivables - Net figures came in at $1.3 million (Q1 2026), $688000.0 (Q4 2025), and $515000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 CG Oncology 6.63 Bn 6.63 Bn -2.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 417,000.00
Jun 30, 2026 417,000.00
Mar 31, 2026 1.28 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 688,000.00
Dec 31, 2025 688,000.00
Sep 30, 2025 515,000.00
Sep 30, 2025 515,000.00
Jun 30, 2025 562,000.00
Jun 30, 2025 562,000.00
Mar 31, 2025 345,000.00
Mar 31, 2025 345,000.00
Sep 30, 2024 137,000.00
Sep 30, 2024 137,000.00
Jun 30, 2024 182,000.00
Jun 30, 2024 182,000.00
Mar 31, 2024 153,000.00
Mar 31, 2024 153,000.00
Dec 31, 2023 92,000.00
Dec 31, 2023 92,000.00